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ReviewGlossary
Cis-acting lncRNA: a lncRNA that functions close to its site of synthesis to
regulate the expression of nearby genes on the same chromosome in an allele-
specific manner.
Enhancer-associated lncRNA: a lncRNA whose genomic locus is marked by
high levels of histone H3 lysine 4 mono- compared to tri-methylation.
Intergenic lncRNA: a lncRNA whose genomic locus does not overlap
transcribed protein coding gene sequence.Several nuclear localised intergenic long noncoding
RNAs (lncRNAs) have been ascribed regulatory roles in
transcriptional control and their number is growing
rapidly. Initially, these transcripts were shown to func-
tion locally, near their sites of synthesis, by regulating
the expression of neighbouring genes. More recently,
lncRNAs have been demonstrated to interact with chro-
matin at several thousand different locations across
multiple chromosomes and to modulate large-scale
gene expression programs. Although the molecular
mechanisms involved in targeting lncRNAs to distal
binding sites remain poorly understood, the spatial or-
ganisation of the genome may have a role in specifying
lncRNA function. Recent advances indicate that inter-
genic lncRNAs may exert more widespread effects on
gene regulation than previously anticipated.
Emerging roles for nuclear lncRNAs
The mammalian genome contains large numbers of non-
coding RNA (ncRNA) loci that interdigitate between, with-
in, and among protein-coding genes on either strand. To
date, more than 10 000 mammalian intergenic lncRNAs
[>200 nucleotides (nt)] (see Glossary) have been catalo-
gued; the majority of these are expressed at lower levels
compared with protein-coding transcripts, and are more
tissue specific [1–3]. A small number of intergenic lncRNAs
have been implicated in a variety of biological processes [4].
The functions, if any, of the remaining transcripts remain
unknown and, in contrast to protein-coding sequence, can-
not yet be predicted from sequence alone [5].
Some intergenic lncRNAs function as transcriptional
regulators that can act locally, near their sites of synthesis,
to regulate the expression of nearby genes, or distally to
regulate gene expression across multiple chromosomes
(Figure 1). Here, we draw upon recent studies to review
the functions of nuclear localised intergenic lncRNAs in
regulating gene transcription and chromatin organisation,
their local and distal modes of action, their mechanisms of
genomic targeting, and the nature of their interactions
with chromatin.0168-9525/
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348 Trends in Genetics, August 2014, Vol. 30, No. 8lncRNAs function at their sites of synthesis to regulate
local gene expression
Intergenic lncRNAs have been divided, on the basis of
chromatin marks at their promoters, into two broad cate-
gories: those emanating from enhancer regions or those
transcribed from promoter-like lncRNA loci [6]. Most, if not
all, transcriptional enhancer elements are transcribed to
produce often exosome sensitive, unspliced transcripts
termed ‘enhancer RNAs’ (eRNAs). The level of these tran-
scripts tends to correlate positively with expression levels
of neighbouring protein coding genes [7,8]. A subset of
enhancers also appears to be associated with polyadeny-
lated, more stable, and often spliced lncRNAs variously
called elncRNAs, 1d-eRNAs, or ncRNA-activating
lncRNAs (ncRNA-a) [6,9–11]. All of these transcripts are
likely generated bidirectionally with RNAs transcribed
from either or both strands being rapidly degraded, as
seen for unstable antisense promoter upstream transcripts
(PROMPTS) [12] and for intragenic enhancer produced
transcripts [13]. Thus, further experiments will be needed
to determine the relative proportions and functions of
enhancer-associated lncRNA loci that are uni- or bi-direc-
tional, capped, and polyadenylated or unpolyadenylated,
and multi- or mono-exonic.
It is currently unknown whether eRNAs or elncRNAs
are commonly simply a by-product of or an actual cause of
enhancer action on neighbouring protein-coding genes.
However, a small but growing number of eRNAs and
elncRNAs have been shown to function at their site of
synthesis in a RNA-dependent manner to regulate posi-
tively the expression of neighbouring protein coding genes
on the same chromosome [14–18]. In one study, multiplelncRNA: an RNA molecule, greater than 200 nt in length, which is not predicted
to encode protein.
Promoter-associated lncRNA: a lncRNA whose genomic locus is marked by
high levels of histone H3 lysine 4 tri-methylation relative to monomethylation.
Proximity transfer: translocation of an RNA molecule from its site of
transcription to distal binding sites, located in close spatial proximity.
Trans-acting lncRNA: a lncRNA that regulates the expression of genes on a
different chromosome and/or on the homologous chromosome from where it
is transcribed.
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Figure 1. Local and distal modes of long noncoding RNA (lncRNA)-mediated transcriptional regulation. (A) DNA looping interactions bring a lncRNA locus into close
physical proximity with a genomically adjacent protein coding gene (PCG). Such lncRNAs function close to their sites of synthesis to regulate the expression of nearby
genes on the same chromosome. (B) Chromatin conformation changes bring two distantly located loci into close spatial proximity. lncRNAs in this category function close
to their site of synthesis, but their genomic PCG targets are located on different or homologous chromosomes (chr). (C) lncRNAs translocate from their sites of synthesis to
regulate transcription of distantly located target genes on the same or different chromosomes.
Review Trends in Genetics August 2014, Vol. 30, No. 817B-oestradiol (E2)-induced eRNA transcripts were found
to interact with cohesin in vitro and to induce looping
interactions between their enhancer elements and the
promoters of nearby target genes [15]. In another, two
elncRNAs (ncRNA-a3 and ncRNA-a7) bound to compo-
nents of the Mediator complex and also promoted enhanc-
er–promoter looping interactions to regulate local gene
expression [19]. In a third study, upon depletion of an
eRNA transcribed from the MyoD1 core enhancer region,
both MyoD1 chromatin accessibility and RNA polymerase
II (PolII) occupancy were reduced and MyoD1 expression
was decreased [17]. Therefore, enhancer-associated tran-
scripts can modulate enhancer activity by altering local
chromatin accessibility and/or structure. Nevertheless,
other studies showed that eRNAs generated from
p53-bound enhancers acted on pre-existing chromatinconformations to increase enhancer activity by unknown
mechanisms [16] and that inhibition of eRNA production at
estrogen receptor (ER) bound enhancers, for example by
blocking transcriptional elongation, had no effect on chro-
matin looping yet still inhibited target gene activation [18].
Thus, enhancer-associated lncRNAs may have multiple
RNA-dependent mechanisms of transcriptional control.
lncRNA loci have also been ascribed RNA-independent
functions in gene activation, for example that arise from
transcription through loci affecting local chromatin acces-
sibility, as described during fbp1+ gene activation in yeast
[20]. In another example, the activity of the human growth
hormone (hGH) HS1 enhancer was shown to be stimulated
by lncRNA transcription that initiates immediately down-
stream of HS1 and is noncontiguous with the hGH target
promoter [21]. To investigate the molecular mechanism of349
Box 1. Mapping genomic binding sites of lncRNAs
Four techniques have been developed recently that map the
interaction of RNA with chromatin: chromatin oligoaffinity precipita-
tion (ChOP); chromatin isolation by RNA purification (ChIRP); capture
hybridisation analysis of RNA targets (CHART); and RNA antisense
purification (RAP) [25–28,50]. Each uses biotinylated antisense
oligonucleotides to capture RNA from cross-linked chromatin ex-
tracts, in combination with quantitative (q)PCR and/or high-through-
put sequencing, to identify their associated DNA binding sites.
Although these techniques are based on an analogous concept, they
differ in their chromatin cross-linking, shearing, and hybridisation
conditions, the size and number of oligonucleotide probes used to
capture target RNAs, and the method of elution of the associated DNA
fragments. Whereas the ChOP method has only been used to examine
RNA occupancy at discrete loci [28,65], ChIRP, CHART, and RAP have
been applied to map RNA chromatin occupancy genome-wide.
A pool of approximately 24 short 20-nt probes are used in ChIRP to
enrich for RNA targets from nonreversible glutaraldehyde cross-
linked extract [25], whereas in RAP a large pool (1054 probes for the
17-kb Xist transcript) of long 120-nt capture oligonucleotides are used
to pull down target transcripts from a combination of glutarate and
formaldehyde cross-linked cells [26]. The use of capture oligonucleo-
tides that span the whole length of the target molecule in both ChIRP
and RAP has been reported to improve the effectiveness of this
approach to uniformly capture long RNAs [25]. Moreover, when RAP
was used to purify the highly abundant Xist transcript from female
lung fibroblasts, approximately 70% of the total RNA-Seq reads in the
pull down corresponded to Xist transcript, representing a massive
enrichment [26]. CHART, by comparison, uses RNaseH sensitivity
mapping to design a small number of 18–28-nt antisense oligonu-
cleotides against regions of the target RNA that are accessible for
hybridisation [48,50]. These are then used to capture RNA targets
from formaldehyde cross-linked chromatin. In the CHART protocol,
hybridisation is performed at room temperature and RNaseH is used
to elute RNA–chromatin complexes that specifically interact with
antisense capture DNA oligonucleotides, which is effective in
reducing the number of false positive interactions that are generated
due to direct DNA binding of antisense oligonucleotides.
The size, abundance, and subcellular localisation of the target RNA
are likely to influence the efficacy of these approaches and, therefore,
the optimal method should be determined for each transcript.
Review Trends in Genetics August 2014, Vol. 30, No. 8this stimulation, a transcriptional terminator was inserted
into the locus, which led to reduced lncRNA transcription,
and to a concomitant decrease in hGH expression. When
the sequence of this lncRNA was replaced by that of an
unrelated bacteriophage RNA, the enhancing effect of the
natural transcript was recapitulated. Taken together,
these studies show that enhancer-associated lncRNAs
can also act locally, near their site of synthesis, using
either RNA-dependent or -independent mechanisms to
increase the transcriptional activity of chromosomally
proximal protein coding genes.
Local changes in gene expression are presumed to be
mediated by cis-acting lncRNA modes of action on the same
chromosome, and in an allele-specific manner. However,
trans-acting lncRNA mechanisms could also operate to
control nearby gene expression. The lncRNA Jpx, for ex-
ample, is transcribed from the active X chromosome and
can upregulate expression of the adjacent Xist gene on the
other future inactive X allele in trans during the process of
X chromosome inactivation [22]. Evf-2, in addition, mod-
ulates the activity of an enhancer element present within
its locus by binding distal-less homeobox 2 (DLX2) and
methyl CpG binding protein 2 (MECP2) and inhibiting
DNA methylation of this enhancer to control expression
of the genomically adjacent Dlx6 gene [23,24]. These effects
occur in trans because Evf-2 and DLX2 cooperate to
increase the activity of the Dlx6 enhancer when they are
co-expressed from transiently transfected plasmids in a
reporter assay, and Evf-2 inhibits DNA methylation when
expressed ectopically from a transgene in a mouse model.
In general, further mechanistic studies will be needed to
assess the relative contributions of cis- and trans-acting
lncRNA mechanisms controlling local gene expression.
lncRNAS with distal regulatory functions
Many experiments thus far have focussed on the possible
mechanisms by which an enhancer-associated lncRNA or
transcription of its locus regulates the expression level of
an adjacent protein-coding gene. However, long-range
intra-chromosomal interactions between eRNA expressing
loci and distantly located loci have also been documented350[15,16]. The TFF1 and NRIP1 eRNA containing loci, locat-
ed 27 Mb apart on chromosome 21, are brought into close
spatial proximity by long-range DNA looping interactions.
This looping is induced by E2 and appears to be dependent
on the NRIP1 eRNA. Therefore, a subset of eRNAs may
have so far uncharacterised distal regulatory roles.
What has been studied less often is whether lncRNA
transcripts can function in trans at distal genomic loca-
tions. To address this and other issues, several techniques
have been recently developed [25–28] to map the occupan-
cy of lncRNAs genome-wide (Box 1). Although these
approaches are providing insights into the direct or indi-
rect binding of RNAs to genomic locations, it is important
also to understand their limitations. One of these is that
false positive inferences can arise from the direct DNA
binding of the antisense oligonucleotides used to capture
the RNA and also from the cross-linking of spatially adja-
cent genomic regions in the nucleus. Interpretation of
results is further complicated by the observation that
the binding of transcription factors to DNA is often insuf-
ficient to alter transcription [29,30]. Thus, we expect that a
large number of lncRNA binding events are also inconse-
quential. For example, one eRNA, transcribed from an E2-
regulated FoxC1 enhancer, has been shown to occupy 15
binding locations on multiple chromosomes, all well away
from its endogenous locus; however, none of these were
located within regulatory regions of E2-responsive genes
and, thus, probably represent nonfunctional genomic inter-
actions [15]. Therefore, to prioritise binding events that are
functional, it is necessary to identify genes that are both
directly bound and regulated by lncRNA transcripts, for
example by intersecting lncRNA genomic binding profiles
with lncRNA-induced gene expression changes.
Determination of the genomic binding profiles for sev-
eral other types of lncRNA shows that a single lncRNA
transcript can interact with multiple binding sites on
different chromosomes away from its site of transcription.
Hotair, a lncRNA transcribed from the homeobox (Hox) C
locus, was shown initially to function in trans to repress the
transcription of genes in the HoxD gene cluster on another
chromosome [31]. Subsequently, it was found to associate
Review Trends in Genetics August 2014, Vol. 30, No. 8with approximately 800 binding locations of up to 1 kb in
length across multiple chromosomes. These focal binding
sites are reported to be embedded within larger polycomb
domains and are enriched within genes that become dere-
pressed upon Hotair depletion [25]. Another lncRNA, pros-
tate-specific transcript 1 (non-protein coding) (PCGEM1),
which binds to the androgen receptor (AR), associates with
2142 binding locations on the genome, the majority (ap-
proximately 70%) of which correspond to AR-bound
H3K4me1-modified enhancers. PCGEM1 association with
AR-bound enhancers appears to increase AR-mediated
gene activation without affecting AR levels [32].lncRNA genomic binding proﬁle
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Review Trends in Genetics August 2014, Vol. 30, No. 8functional Paupar binding sites were predicted to be only
those within the regulatory regions of genes that were
differentially expressed upon Paupar depletion. Paupar
was then shown using reporter assays to modulate the
transcriptional activity, in trans and in a dose-dependent
manner, of three out of five such candidate regions tested.
These experiments demonstrate that a lncRNA can have
dual functions both locally, to regulate the expression of its
neighbouring protein coding gene, and distally at regulatory
elements genome-wide. In this case, the distal functions of
Paupar rely, in part, on it being guided to its genomic binding
sites by formation of a complex with PAX6, a DNA-binding
protein.
The Firre lncRNA also appears, from its genome-wide
binding profile, to act locally as well as distally. It occupies
a large 5-Mb domain surrounding its site of synthesis on
the X chromosome and interacts with five additional
domains on four different autosomes [34]. Only one of these
binding events was shown to alter the expression of a gene
within the bound region. The ncRNA Ctbp1-as has also
been shown to function both locally, to repress Ctbp1
expression through a sense-antisense mediated mecha-
nism, and distally to increase AR transcriptional activity
in prostate cancer cells [35].
Although such studies are as yet limited in number,
they suggest that the ability of lncRNAs to function both
locally, as well as distally, to regulate large-scale gene
expression programs may be more widespread than origi-
nally anticipated. As genome-wide binding profiles for
more lncRNAs are mapped and their direct transcriptional
targets are identified, there will be increasing opportu-
nities to elucidate their presumed heterogeneous molecu-
lar mechanisms (Figure 2).
lncRNA genome targeting
The mechanisms by which lncRNAs target specific genomic
sequences are not understood. It is easy to envisage that
lncRNA transcripts could participate in regulating local
gene expression by accumulating to comparatively high
concentrations at their sites of synthesis. However, it is
more difficult to explain how lowly expressed, and often
unstable, nuclear lncRNAs act by binding many different
chromosomal regions that lie distant to their site of tran-
scription. Recent reports suggest that the 3D conformation
of the genome guides lncRNAs to distal binding sites. This
process of ‘proximity transfer’ was first proposed for Xist on
the basis of its transferral from its site of synthesis to
distal, yet spatially close, binding sites along the X chro-
mosome; however, confirmation of this model will require
data at higher resolution than the 1-Mbp intervals used in
the initial study [26].
The mechanism of proximity transfer is further sup-
ported by observations concerning the Hottip lncRNA lo-
cus. Chromosomal looping interactions were found that
brought this locus into close spatial proximity to its target
genes in the HOXA cluster [36]. Furthermore, transcrip-
tion was activated when the Hottip transcript was
recruited to its target promoters in reporter assays, where-
as induction of Hottip expression from an ectopic site had
no effect [36]. The spatial organisation of the genome might
also permit lncRNAs to span multiple binding locations352across different chromosomes, including their sites of syn-
thesis. Consistent with this, the binding domains of Firre
on different chromosomes appear to be located in close
spatial proximity within the nucleus [34].
Several nuclear lncRNAs are able to regulate transcrip-
tion when expressed in trans from ectopic loci
[22,24,33,37]. This suggests an alternative model in which
lncRNAs are translocated from their site of synthesis as
components of ribonucleoprotein complexes to bind specif-
ically and regulate the expression of distantly located
target genes. One such lncRNA could be NeST, which is
involved in controlling the immune response to microbial
infection. NeST can activate interferon gamma (Ifn)g tran-
scription in trans, both when expressed from a transgene
and also from its genomic locus, by interacting with WD
repeat domain 5 (WDR5) and by altering Ifng histone
H3K4 tri-methylation [37]. Additionally, and in contrast
to the proximity transfer model, Xist might be a diffusible
factor; when Xist is expressed from a transgene in female
mouse embryonic fibroblasts, it diffused from the ectopic
site of synthesis and acted on the endogenous Xist locus in
trans [38]. Similarly, Evf-2, when expressed from a tran-
siently transfected plasmid, cooperated with the DLX2
protein to activate the Dlx-5/6 enhancer in a luciferase
reporter in trans [24], and depletion of the endogenous
Paupar transcript modulated, in a dose-dependent man-
ner, the transcriptional activity of a number of its genomic
binding sites when inserted into transiently transfected
reporters [33].
Therefore, coordination among sites of lncRNA synthe-
sis, the spatial organisation of the genome in the nucleus,
and specific lncRNA interactions with transcription and
chromatin regulatory proteins are all likely to have roles in
facilitating binding of lncRNA transcripts to their genomic
targets (Figure 2).
lncRNA–chromatin interactions
The genomic associations observed between lncRNAs and
chromatin could be accomplished through direct base pair-
ing between RNA and DNA sequences [39] (Figure 3A).
This is exemplified by promoter associated RNA (pRNA), a
low-abundance RNA transcribed from upstream of the pre-
rRNA transcription start site that can interact with com-
plementary sequences within the rDNA promoter forming
a RNA–DNA–DNA triplex, possibly through Hoogsteen
base-pairing [40]. Furthermore, because RNA base pairs
with itself, RNA–RNA interactions between complemen-
tary sequences at transcribed loci could also guide
lncRNAs to their genomic targets (Figure 3B). It remains
unclear how widespread direct RNA–DNA or RNA–RNA
targeting may be.
lncRNAs that associate with sequence-specific DNA
binding transcription factors could be targeted to the
genome indirectly through RNA–protein–DNA interac-
tions (Figure 3C). YY1, for example, is a zinc finger-con-
taining transcription factor that may recruit Xist to
chromatin by binding DNA and Xist RNA through different
sequence domains [38]. Other candidates for RNA–protein
DNA-binding complexes include Gas5 and glucocorticoid
receptor [41], Panda and nuclear transcription factor Y
(NFYA) [42], Lethe and nuclear factor kB (NF-kB) [43], Jpx
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Figure 3. Different modes of long noncoding RNA (lncRNA)–chromatin
association. (A) Single-stranded lncRNAs directly interact with complementary
double-stranded DNA target sequences through hydrogen bonding to form a RNA-
DNA-DNA triplex structure. lncRNAs are predicted to bind in the major groove of
the DNA through either Hoogsteen or reverse Hoogsteen base pairing. (B) lncRNAs
base pair with RNA sequences at transcribed loci. This may involve Watson–Crick
base pairing (G–C, A–U) between complementary nucleotides as well as non-
Watson–Crick base pairing (G–U, A–A) which does not require exact sequence
complementarity. (C) Indirect recruitment of lncRNAs to the genome through
RNA–protein–DNA interactions. This includes lncRNA associations with sequence
specific DNA binding transcription factors, non-DNA binding transcriptional
cofactors and histone proteins. Post-translational histone modifications, such as
acetylation, methylation, and ubiquitination, may influence lncRNA–histone
binding.
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[33], Rmst and SRY (sex determining region Y)-box (SOX2)
[45], and Prncr1 and AR [32]. Each of the Gas5, Panda,
Lethe, and Jpx lncRNAs appears to inhibit DNA binding of
their associated transcription factors at several target
sites, whereas knockdown of Paupar and Prncr1 levels
had no effect on PAX6 or AR occupancy where tested.
By contrast, Rmst appears to be required for the correctassociation of SOX2 with promoter regions of neurogenic
target genes [45]. Therefore, lncRNAs can actively modu-
late the DNA binding activity of their associated transcrip-
tion factors as well as acting as non-DNA binding cofactors,
as has been described for Six3OS and SRA [46,47], whose
precise regulatory roles need to be investigated.
Chromatin modification and structure may also modu-
late how lncRNAs are recruited to the genome. Xist
appears to target active chromatin because domains that
are initially occupied by Xist are unusually enriched in
actively transcribed genes and open chromatin [48], where-
as AR-associated lncRNAs Pcgem1 and Prncr1 preferen-
tially interact with enhancer-associated histone
modifications in vitro [32]. Computational approaches
are beginning to predict how lncRNAs interact with chro-
matin or DNA: firstly, by suggesting the candidature of
lncRNA-associated transcription factors from enrichments
of their binding motifs; secondly by proposing the involve-
ment of the lncRNA in transcriptional enhancement or
repression from enrichments of relevant chromatin marks;
and thirdly by identifying near complementary DNA
sequence within lncRNA-associated regions that might
indicate direct RNA–DNA–DNA triplex formation
[25,33,49,50].
Mechanisms of action
Several lncRNAs associate with chromatin-modifying com-
plexes and transcriptional regulatory proteins in the nu-
cleus. High throughput RNA-immunoprecipitation (RNA-
IP) experiments have indicated that individual chromatin-
modifying complexes, such as polycomb repressive complex
2 (PRC2) and mixed-lineage leukemia (MLL), interact with
thousands of RNA transcripts, including lncRNAs [51,52].
However, substantial numbers of transcripts are known to
bind nonspecifically and reproducibly with various RNA-
binding proteins in RNA-IP based assays [53]. Further-
more, purified PRC2 complex, for example, binds RNA
nonspecifically in vitro in a size-dependent manner [54].
Thus, studies will need to distinguish specific from non-
specific RNA–protein interactions.
lncRNAs that bind proteins specifically might act as
guides to target chromatin-modifying complexes to the
genome. The lncRNA Mistral, for example, which is tran-
scribed from the intergenic region between the Hoxa6 and
Hoxa7 genes, forms a RNA–DNA hybrid structure at its
site of synthesis which recruits MLL1 complex proteins
[55]. By contrast, the lateral mesoderm-specific lncRNA
Fendrr can associate with PRC2 and regulate Pitx2 expres-
sion in trans. Fendrr is predicted to interact with a short
stretch of complementary sequence, of fewer than 40 nt, in
the Pitx2 promoter, which can form a RNA–DNA–DNA
triplex in vitro. Given that Pitx2 promoter PRC2 occupancy
and histone H3K27 tri-methylation are decreased in
Fendrr knockout embryos, Fendrr may have a role in
recruiting PRC2 to the Pitx2 promoter [56]. Thus, such
nuclear lncRNAs have the potential to target chromatin
remodelling complexes either to their sites of synthesis or
to distally located loci in trans.
Several recent studies suggest that lncRNAs modulate
the structure and function of their associated protein com-
plexes. The Drosophila roX2 lncRNA appears to function as353
Review Trends in Genetics August 2014, Vol. 30, No. 8a critical complex subunit that is necessary for the correct
assembly of a functional male-specific lethal (MSL) dosage
compensation complex. Its stem loop-containing structured
domains bind the MLE RNA helicase and MSL2 ubiquitin
ligase components of the MSL dosage compensation com-
plex in a sequential manner [57,58]. Interaction of roX2 with
the MLE RNA helicase results in an ATP-dependent con-
formational change in a roX2 stem-loop structure and a
subsequent increase in its association with MSL2. Other
lncRNAs may also promote the ordered recruitment of
functional ribonucleoprotein complexes. For example,
Pcgem1 and Prncr1 bind AR sequentially, thereby stimulat-
ing both ligand-dependent and ligand-independent AR con-
trolled gene expression programs [15]. Prncr1 first
associates with DOT1-like, histone H3 methyltransferase
(DOT1L) and binds to acetylated enhancer-bound AR caus-
ing DOT1L to methylate the AR. AR methylation subse-
quently induces recruitment of Pcgem1, in complex with
pygopus homolog 2 (PYGO2), which because of its
H3K4me3-binding ability, may stimulate DNA looping
interactions between AR-bound transcriptional enhancers
and target promoters.
These studies raise the possibility that a single lncRNA
molecule contains multiple structural motifs, upon which
multiple different proteins bind, which enhance the effi-
ciency of genomic targeting and transcriptional regulation
[59]. Hotair, for example, interacts with PRC2 through its
50 end, whereas its 30 region associates with (co)repressor
for element-1-silencing transcription factor (CoREST) in
vitro [60]. A scaffolding role for lncRNAs may also translo-
cate gene loci between different nuclear compartments to
allow transcriptional activation or repression in response
to various stimuli. This is exemplified by the differential
interactions of taurine upregulated 1 (Tug1) and metasta-
sis associated lung adenocarcinoma transcript 1(Malat1)
with methylated and unmethylated Pc2 protein, respec-
tively, and the subsequent relocation of growth control
genes from Tug1-containing polycomb bodies, where they
are repressed, to interchromatin granules for assembly of
activator complexes, where they are activated [61].
Concluding remarks
Roles for lncRNAs as regulators of chromatin organisation
and gene expression were initially described for H19 and
Xist lncRNAs in genomic imprinting and X chromosome
inactivation, respectively. It has since become apparent
that the genome encodes large numbers of nuclear local-
ised intergenic transcripts. The number of these tran-
scripts that derive from serendipitous transcription or
that fail to have functions (as opposed to mere effects
[62]) remains unknown. Evolutionary evidence for selected
effect functionality [62] of lncRNAs, in general, is meagre
[3,63] and the proportion of lncRNA sequence that is under
purifying selection appears to be small, approximately 5%
[64]. Therefore, further detailed studies on a larger sample
of lncRNAs are needed to estimate the proportion of
lncRNAs that are functional, as well as to define their
structure–function relations, and to better understand the
mechanisms of these transcripts in regulating genome
organisation and gene transcription. We also await the
results of lncRNA loss-of-function studies in animal model354systems that discriminate lncRNA from DNA sequence-
mediated effects that might identify nuclear lncRNAs that
are essential for embryonic development and adult tissue
homeostasis in vivo.
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